Immunostimulatory Adjuvants Market - Size, Share, Outlook, and Forecast till 2026

Immunostimulatory adjuvants are specific class of compounds, which are added in vaccines to enhance immune response of body against specific antigen. Immunostimulators activate the immune system by accelerating activity of any of its components. An adjuvant is a component that potentiates the immune responses to an antigen and/or modulates it towards the desired immune responses. An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens.

Immunologic adjuvants are majorly used to enhance vaccine potency by improvement of the humoral and/or cell-mediated immune response to vaccine antigens. This can be used to develop vaccine for prevention of various viral infections, which in turn is driving growth of the immunostimulatory adjuvants market. Therefore, development of vaccines with appropriate adjuvants is an attractive approach towards eliciting protective and long-lasting immunity in humans. The use of appropriate adjuvants allows vaccine formulations that selectively trigger innate immunity and/or adaptive immunity to obtain a desired type of antigen-specific immune responses. However, only a limited number of adjuvants is licensed for human vaccines due to complications regarding safety and toxicity, which is key factor restraining growth of the immunostimulatory adjuvants market.

Key developments of Immunostimulatory Adjuvants Market

Market players are engaged in developing novel vaccines containing immunostimulatory adjuvants in order to meet increasing demand from healthcare sector. Furthermore, approval of novel drugs and guidelines regarding utilization of adjuvants by regulatory bodies is fueling growth of the immunostimulatory adjuvants market. For instance, in May 2018, the Centers for Disease Control and Prevention's (CDC) Advisory Committee published guidance on use of Heplisav-B (HepB-CpG), a new vaccine that protects against hepatitis B virus (HBV) infection. The new vaccine is one of five approved inactivated HBV vaccines. Heplisav-B contains a novel immunostimulatory sequence adjuvant. Two doses are administered just 1 month apart, making it an important option for prevention of HBV.

In February 2018, researchers from Kawasaki Institute of Industrial Promotion, The University of Tokyo, Tokyo Medical and Dental University, and Osaka Prefecture University, enhanced adjuvant properties of the RNA by utilizing the high immunogenicity of double stranded (ds)RNA. The dsRNA comprised mRNA itself and an RNA strand complementary to the poly A region of the mRNA. The study aimed to develop significant immune stimulation in a cell line and bone-marrow-derived APCs in vitro. Key players operating in immunostimulatory adjuvants market include Recenttec, Bayer AG, Adjuvance Technologies, Vical, Allergy Therapeutics, and BioCentury.

Global Vaccine Adjuvants Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been ...

Global Veterinary Vaccine Adjuvants Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vacci...

EMEA (Europe, Middle East and Africa) Human Vaccine Adjuvants Market Report 2017

Published Date : Oct 2017

In this report, the EMEA Human Vaccine Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sa...

Global Vaccine Adjuvants Market

Published Date : Dec 2018

The global Vaccine Adjuvantsmarket was valued at USD 466.92 million in 2016 and is projected to reach USD 1140.32millionby 2025, growing at a CAGR of 10.43% from 2017 to 2025. An adjuvant is a substance that is added to a vaccine to increase the body's immune response to the vaccine. Vaccines...

Global Agricultural Adjuvants Market

Published Date : Dec 2018

Market Overview: The global Agricultural Adjuvantsmarket was valued at USD 2.65billion in 2016 and is projected to reach USD 4.33billionby 2025, growing at a CAGR of 18.0% from 2017 to 2025. Adjuvants are products that are sprayed on plants to increase the effectiveness of insecticides,...

Asia-Pacific Agricultural Adjuvants Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Agricultural Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sa...

EMEA Vaccine Adjuvants Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Published Date : Oct 2017

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been ...

Global Agricultural Adjuvants Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Agricultural Adjuvants in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufa...

Global Human Vaccine Adjuvants Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Human Vaccine Adjuvants in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manuf...

Global Agricultural Adjuvants Sales Market Report 2017

Published Date : Sep 2017

In this report, the global Agricultural Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), ...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.